Trillium Therapeutics Provides Update on Its TTI-621 and TTI-622 Clinical Programs

NEXT STORY
Helix BioPharma Corp. Announces Regulatory Approval to Dose Patients in a Phase II Randomized Study of L-DOS47 With Vinorelbine and Cisplatin
PREV STORY
Loxo Oncology and Illumina to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Invuity to Present at Upcoming Conferences

SAN FRANCISCO, Nov. 09, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading surgical ...

author_avatar
NASDAQ Market News

Digital Pathology Market to Surpass US$ 900 Mn by 2026; Rise in Installation of Digital Pathology Systems to Boost Market: Transparency Market Research

Digital Pathology Market (Product Type - Image Analysis Software and Scanners; End use - ...

author_avatar
NASDAQ Market News

Ziopharm Oncology and TriArm Therapeutics Establish Joint Venture to Develop and Commercialize Sleeping Beauty CAR T in China, Taiwan and Korea

-- Joint venture to operate as Eden BioCell -- -- TriArm Therapeutics, a Panacea ...

author_avatar
NASDAQ Market News